Physician profile
Timothy E Newhook
NPI 1700101029
$9,670.34
in general payments reported to CMS, 2019-2025
9 companies · $1,094 in 2025
The $1,094 reported for 2025 was more than what a typical Surgical Oncology provider received nationally (typical 2025 total: $288).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,755 · 2020: $198 · 2022: $2,330 · 2023: $191 · 2024: $2,102 · 2025: $1,094.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,987 · Travel and Lodging: $1,400.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,986.71 |
| Travel and Lodging | $1,400.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,899.56 | 2019-2023 | Da Vinci Surgical System |
| Bayer Healthcare Pharmaceuticals INC. | $1,853.13 | 2022 | |
| Histosonics, INC. | $1,473.21 | 2024 | |
| Integra Lifesciences Corporation | $641.24 | 2020-2025 | Codman Certas, Cusa Clarity, Codman Hakim |
| Ethicon US, LLC | $585.48 | 2023-2025 | Dermabond Prineo, Echelon Endopath, Enseal |
| Medtronic, INC. | $581.74 | 2022-2025 | Signia, Mcgrath Mac, Emprint |
| Intera Oncology, INC | $427.32 | 2025 | Intera |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $107.24 | 2025 | |
| Medical Device Business Services, INC. | $101.42 | 2025 | Enseal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Newhook listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.